IP Library Granted Patent US 11,879,141
Granted Patent B2
US 11,879,141 · App. 18/342,874 · Granted Jan 23, 2024

Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same

Inventor: Wayne K. Herber (Coopersburg, PA)
Assignee: Endo Global Ventures
C12N9/52C12N9/50C12Y304/24003A61K38/4886C12Q1/37G01N33/5044G01N33/56911G01N2333/96419Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,879,141
App. No.
18/342,874
Granted
Jan 23, 2024
Kind
B2
Abstract

The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The invention also encompasses methods related to releasing a composition comprising collagenase prior to therapeutic administration.

Claims (12)

1. A recombinant nucleic acid molecule, comprising:

a polynucleotide encoding the amino acid sequence of SEQ ID NO: 6; and

a heterologous regulatory sequence operably linked to the polynucleotide.

2. The recombinant nucleic acid molecule of claim 1 , wherein the heterologous regulatory sequence is a promoter.

3. The recombinant nucleic acid molecule of claim 1 , wherein the recombinant nucleic acid molecule is fused to a marker sequence.

4. The recombinant nucleic acid molecule of claim 3 , wherein the marker sequence encodes a polypeptide selected from a glutathione-S-transferase (GST) fusion protein, a hemagglutinin A (HA) polypeptide from influenza, and a hexa-histidine peptide.

5. A vector comprising the recombinant nucleic acid molecule of claim 1 .

6. The vector of claim 5 , wherein the vector is a plasmid.

7. A recombinant host cell comprising the vector of claim 5 .

8. The recombinant host cell of claim 7 , wherein the host cell is selected from a bacterial cell, a fungal cell, an insect cell, a plant cell, and a mammalian cell.

9. The recombinant host cell of claim 8 , wherein the host cell is E. coli , a Streptomyces species, a Pseudomonas species, Serratia marcescens, Salmonella typhimurium , a yeast cell, a plant cell, a thymocyte, a Chinese hamster ovary cell (CHO), a COS cell, or Lactococcus lactis.

10. A method of producing collagenase II, the method comprising culturing the recombinant host cell of claim 7 under conditions suitable for expression of the polynucleotide and recovering the collagenase II.

Assignments (4)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE PREVIOUSLY LISTED APPLICATION NUMBERS 10603365 AND 11879141 PREVIOUSLY RECORDED AT REEL: 67199 FRAME: 31. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 10, 2024
From: ENDO GLOBAL VENTURES
To: PALADIN PHARMA INC.
Reel/Frame 067622/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0736 →